New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

4D Molecular Therapeutics, Inc.

Contributing Author

Recent Articles by 4D Molecular Therapeutics, Inc.

Sep-12	4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Sep-02	4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness FDMT GlobeNewswire
Aug-25	4DMT to Participate in Upcoming Investor Conferences FDMT GlobeNewswire
Aug-15	4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Aug-11	4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones FDMT GlobeNewswire
Aug-06	4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference FDMT GlobeNewswire
Jul-31	4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update FDMT GlobeNewswire
Jul-24	4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists FDMT GlobeNewswire
Jul-11	4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Jul-02	4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution FDMT GlobeNewswire
May-28	4DMT to Participate in Upcoming Investor Conferences FDMT GlobeNewswire
May-16	4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
May-08	4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones FDMT GlobeNewswire
May-05	4DMT to Participate in Upcoming Investor Conferences FDMT GlobeNewswire
May-01	4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME FDMT GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.